The Luxturna treatment, carried out at the Vision Center at the Children’s Hospital Los Angeles (CHLA), replaces the defective gene RPE65 – responsible for producing a protein that makes light receptors work – with a healthy copy made from artificial DNA.
Sign in to continue
Not already a member of the College?
Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.